Skip to content

Robotic versus Laparoscopic Right Colectomy for Colon Cancer: A Multi-center Target Trial Emulation

Robotic versus Laparoscopic Right Colectomy for Colon Cancer: A Multi-center Target Trial Emulation

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126338
Enrollment
Unknown
Registered
2026-06-08
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Right-Sided Colon Adenocarcinoma

Interventions

Intention-to-Treat Laparoscopic Surgery Group:None
Intention-to-Treat Robotic Surgery Group:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years; 2.Right-sided colon adenocarcinoma confirmed by preoperative imaging and/or endoscopic biopsy, with the tumor located in the cecum, ascending colon, hepatic flexure, or the right one-third of the transverse colon; 3.Complete preoperative staging data, with clinical stage I-III (AJCC 8th edition) and no evidence of distant metastasis; 4.Tumor deemed resectable by imaging, with no invasion of major vessels, nerves, or bones; for T4 tumors, no invasion of adjacent organs and no evidence of peritoneal carcinomatosis; 5.Patient fit for radical minimally invasive surgery (ASA score I-III) with no absolute contraindications;

Exclusion criteria

Exclusion criteria: 1.Emergency surgery due to intestinal obstruction, perforation, or acute bleeding; 2.Receipt of neoadjuvant therapy; 3.History of major abdominal surgery involving intestinal resection; 4.Concomitant history of other active malignancies (except for cured basal cell carcinoma of the skin, cervical carcinoma in situ, etc.); 5.Concomitant inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis); 6.Incomplete clinical data or severe deficiency of key variables preventing effective analysis.

Design outcomes

Primary

MeasureTime frame
Incidence of serious postoperative complications within 30 days;

Secondary

MeasureTime frame
3-year Overall Survival (OS);3-year Disease-Free Survival (DFS);Operative Time;Intraoperative Blood Loss;Time to First Liquid Intake;Postoperative Hospital Stay;Postoperative White Blood Cell Count;Postoperative C-reactive Protein Level;

Countries

China

Contacts

Public ContactDaisheng

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

daimd@zju.edu.cn+86 13575472669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026